TherapeuticsMD, Inc. Revenue 2011–2025
TherapeuticsMD, Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- TherapeuticsMD, Inc. revenue for the quarter ending March 31, 2026 was 724000, a 84.22% increase year-over-year.
- TherapeuticsMD, Inc. revenue for the twelve months ending March 31, 2026 was 2.9 M, a 174.06% increase year-over-year.
- TherapeuticsMD, Inc. annual revenue for 2025 was 3.0 M, a 71.61% increase from 2024.
- TherapeuticsMD, Inc. annual revenue for 2024 was 1.8 M, a 35.25% increase from 2023.
- TherapeuticsMD, Inc. annual revenue for 2023 was 1.3 M, a 98.14% decrease from 2022.
- TherapeuticsMD, Inc. annual revenue for 2022 was 70.0 M.
TherapeuticsMD, Inc. (TXMD) — Frequently Asked Questions
TherapeuticsMD, Inc. (TXMD) is a publicly traded US company. It has a market capitalization of $21M. In fiscal 2025 it reported revenue of $3M and net income of -$569,000. Explore TXMD's stock price, financial statements, earnings history, margins and key ratios below.
What is TherapeuticsMD, Inc.'s market cap?
TherapeuticsMD, Inc. (TXMD) has a market capitalization of $21M.
What is the TXMD stock price?
TXMD trades at $1.83 (-1.61% on the day).
How much revenue does TherapeuticsMD, Inc. make?
TherapeuticsMD, Inc. reported revenue of $3M in fiscal 2025.
Is TXMD profitable?
In fiscal 2025, TherapeuticsMD, Inc. reported net income of -$569,000.